Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2353${count})

  • Alpha-synuclein Pathology, 2014
    Development of Diagnostic Biomarker Tests for Parkinson’s Disease

    Study Rationale:       
    An early diagnostic test to identify those with Parkinson’s disease (PD) and to intervene with therapies as early as possible is a critical unmet need. Recent studies have...

  • Research Grant, 2014
    Development and Validation of Biomarker Assays for Improved Diagnosis of Parkinson’s Disease: The Second Generation of Synuclein Assays

    Study Rationale:                   
    Lewy bodies composed primarily of the protein alpha-synuclein are important hallmarks of Parkinson’s disease (PD). Available data on the clinical use of alpha...

  • Research Grant, 2014
    Genetic Predictors of Prognosis: GBA and SNCA Meta-Analysis Project

    Study Rationale:                   
    Predicting the prognosis of Parkinson’s disease (PD) for a patient is currently not possible. Genetic predictors of prognosis would help inform clinical trial design...

  • Access to Data and Biospecimens, 2014
    Analysis of Brain and Peripheral Small Molecule Levels in Parkinson’s Disease

    Study Rationale:
    Parkinson’s disease is accompanied by a loss of chemical signaling molecules in the brain and body. For instance, chemicals like dopamine are lost in both the gut and in the brain...

  • Rapid Response Innovation Awards, 2014
    Exploration of Relationships and Formulations of Molecular Tweezers

    Study Rationale:                   
    A key mechanism leading to death of neurons in the brain is formation of toxic clumps of the protein alpha-synuclein. Therefore blocking the formation of these toxic...

  • Access to Data and Biospecimens, 2014
    Verification of a Long, Non-coding RNA in Blood as a Biomarker for Parkinson's Disease

    Study Rationale:       
    We have discovered a long, non-coding RNA (RNA that does not encode a protein) that shows a five-fold decrease within the brains of people with Parkinson’s disease (PD) compared...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.